Add to cart
Sale!

Retatrutide (10mg & 30mg)

Price range: 4,995 ฿ through 7,995 ฿

-50%

Retatrutide (LY3437943) is an investigational GIP, GLP-1 and glucagon triple receptor agonist currently being studied in Phase 3 clinical trials.

It is different from semaglutide and tirzepatide because it activates three metabolic hormone receptors rather than one or two.

Add to Cart
Retatrutide 10mg and 30mg Cat Pharmaceuticals Thailand
Retatrutide (10mg & 30mg)
4,995 ฿ 7,995 ฿Price range: 4,995 ฿ through 7,995 ฿
🔥 Add 3 more items to get 10% off your order!
Buy ANY 3+ Items & SAVE 10-30%
# ItemsYour DiscountYou Pay
3 - 510%-
6 - 915%-
10 - 1420%-
15 - 2525%-
26 - 4030%-

Free shipping in Thailand

  • Purity guaranteed
  • Shipped within 24 hours
  • 3rd party lab tested and verified
Guaranteed Safe Checkout

Retatrutide · Triple Agonist · 10mg & 30mg Vials

Retatrutide 10mg & 30mg

Retatrutide is a once-weekly peptide that works on GLP-1, GIP and glucagon receptors. This triple-agonist action is why it has attracted so much attention for appetite control and weight loss.

Thai Anabolics offers 10mg and 30mg Cat Pharmaceuticals vials. Both are supplied as powder and can be mixed to the concentration that works best for your weekly dose.

Available Strengths
10mg & 30mg
Frequency
Once weekly
Brand
Cat Pharmaceuticals
Receptors
GLP-1 + GIP + Glucagon

Choose your vial

Retatrutide 10mg or 30mg

10mg vial

Good for Lower Weekly Doses

The 10mg vial is a good choice for customers starting at a lower weekly dose or who want to see how they respond before moving to a larger vial.

Total Retatrutide: 10mg per vial

30mg vial

Better Value for Longer Use

The 30mg vial gives three times as much Retatrutide and is the better option for customers using higher weekly doses or planning a longer fat-loss phase.

Total Retatrutide: 30mg per vial

Weekly dosage

Retatrutide Dosage

Retatrutide is used once per week. Start low and only increase when you need more appetite control or your weight loss has slowed.

StageWeekly Dose
Low Dose1mg once weekly
Starting Dose2mg once weekly
Next Step4mg once weekly
Higher Dose6mg once weekly
Advanced9mg once weekly
Highest Trial Dose12mg once weekly

A simple approach is to stay at each dose for around 4 weeks before increasing. The major Phase 3 trials used 2mg → 4mg → 6mg → 9mg → 12mg steps for the highest-dose group.[1]

You do not have to keep increasing. If appetite is controlled and your weight is moving in the right direction, stay at the dose that is already working.

Lower-dose use

Does 1mg Retatrutide Work?

Yes. A lower weekly dose can still produce results.

In the Phase 2 obesity trial, the fixed 1mg once-weekly group lost an average of 8.7% of bodyweight at 48 weeks.[2]

For clients who get strong appetite control at 1mg, there is no reason to rush straight to the higher trial doses.

Mixing guide

How to Mix Retatrutide

A simple option is to add 1ml of sterile water to either vial. This keeps the math easy and makes the 30mg vial especially convenient for higher weekly doses.

VialAdd Sterile WaterFinal Concentration
10mg vial1ml10mg/ml
30mg vial1ml30mg/ml

10mg Vial + 1ml Water

Retatrutide DoseU-100 Syringe
1mg10 units
2mg20 units
4mg40 units
6mg60 units
9mg90 units

30mg Vial + 1ml Water

Retatrutide DoseU-100 Syringe
1mg3.3 units
2mg6.7 units
4mg13.3 units
6mg20 units
9mg30 units
12mg40 units

Using a different amount of sterile water? Use our Peptide Calculator → to calculate the correct syringe amount.

Triple agonist

Why Retatrutide Is Different

Semaglutide mainly targets GLP-1. Tirzepatide targets GLP-1 and GIP. Retatrutide adds a third target: the glucagon receptor.

That GLP-1 + GIP + glucagon combination is why Retatrutide is often called a triple agonist.

Weight-loss results

How Much Weight Did Retatrutide Users Lose?

In the 2026 TRIUMPH-1 Phase 3 trial, average weight loss at 80 weeks reached:

4mg: 19.0%
9mg: 25.9%
12mg: 28.3%

The 12mg group lost an average of about 70.3 lb / 31.9kg.[1]

Cutting & fat loss

Using Retatrutide for a Cutting Phase

Retatrutide is useful during a cutting phase because appetite control makes it much easier to stay in a calorie deficit for several weeks or months.

It can be used alongside anabolic steroids, HGH, SARMs, peptides and normal sports supplements. The Retatrutide dose should still be based on your appetite and rate of weight loss rather than trying to match the dose to another compound in the cycle.

The goal is not to use the highest dose possible. The goal is to use enough to control hunger and keep fat loss moving.

Storage

Retatrutide Storage

Before mixing: keep the vial cool, dry and protected from direct light.

After mixing: keep refrigerated at approximately 2°C–8°C. Do not freeze.

Independent testing

Retatrutide 10mg Lab Report

The Cat Pharmaceuticals Retatrutide 10mg vial was independently tested by OnSet Biological Testing Laboratory.

Laboratory
OnSet Biological Testing Laboratory
Report
26-013058
Report Date
2 February 2026
Lot
TR7364
Test
Retatrutide (HPLC)
Result
10.19mg/vial
Purity: 99.51% · Specification: NLT 10mg/vial


Cat Pharmaceuticals Retatrutide 10mg independent HPLC lab report 26-013058

Independent testing

Retatrutide 30mg Lab Report

The Cat Pharmaceuticals Retatrutide 30mg vial was independently tested by OnSet Biological Testing Laboratory.

Laboratory
OnSet Biological Testing Laboratory
Report
26-180349
Report Date
18 August 2026
Lot
TR8637
Test
Retatrutide (RP-HPLC-UV)
Result
32.06mg/vial
Purity: 99.82% · Specification: NLT 30mg/vial


Cat Pharmaceuticals Retatrutide 30mg independent RP-HPLC-UV lab report 26-180349

Thailand delivery

Buy Retatrutide 10mg or 30mg in Thailand

Choose the Cat Pharmaceuticals 10mg or 30mg vial from the options above. The 10mg vial is ideal for lower weekly doses, while the 30mg vial gives better value for longer use and higher doses.

Shipping & Delivery Details →

Sources

Retatrutide Sources

  1. Eli Lilly and Company.
    TRIUMPH-1 Phase 3 Retatrutide Results.
    May 2026. At 80 weeks, average bodyweight reductions were 19.0% at 4mg, 25.9% at 9mg and 28.3% at 12mg.
    View Phase 3 results
  2. Jastreboff AM, Kaplan LM, Frías JP, et al.
    Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.
    New England Journal of Medicine. 2023;389:514–526. The fixed 1mg once-weekly group lost an average of 8.7% bodyweight at 48 weeks.
    View study
Adrian, founder of Thai Anabolics

Written by


Founder of Thai Anabolics · Former Professional Bodybuilder · 20+ Years in the Fitness Industry

Adrian writes practical, experience-led content covering fat loss, cutting, peptides, dosage and performance enhancement in Thailand. On this page, the focus is Retatrutide dosage, low-dose use, mixing, cutting, weight-loss results and independent testing.

Additional information

Vial Strength

,